Jaume Campistol

4.0k total citations
99 papers, 2.4k citations indexed

About

Jaume Campistol is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, Jaume Campistol has authored 99 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Clinical Biochemistry, 57 papers in Molecular Biology and 20 papers in Physiology. Recurrent topics in Jaume Campistol's work include Metabolism and Genetic Disorders (59 papers), Mitochondrial Function and Pathology (31 papers) and Diet and metabolism studies (18 papers). Jaume Campistol is often cited by papers focused on Metabolism and Genetic Disorders (59 papers), Mitochondrial Function and Pathology (31 papers) and Diet and metabolism studies (18 papers). Jaume Campistol collaborates with scholars based in Spain, Netherlands and Germany. Jaume Campistol's co-authors include Rafael Artuch, María Antònia Vilaseca, Rosa Gassió, Àngels García‐Cazorla, Nilo Lambruschini, Belén Pérez‐Dueñas, Aída Ormazábal, Carmen Fons, Emilio Fernández‐Álvarez and Antònia Ribes and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and American Journal of Clinical Nutrition.

In The Last Decade

Jaume Campistol

97 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaume Campistol Spain 29 1.3k 1.2k 484 356 354 99 2.4k
Silvia Tortorelli United States 30 1.1k 0.9× 1.0k 0.9× 621 1.3× 364 1.0× 514 1.5× 70 2.3k
Sylvia Stöckler Canada 22 1.2k 1.0× 1.0k 0.8× 465 1.0× 388 1.1× 288 0.8× 81 2.4k
Johan L.K. Van Hove United States 32 2.0k 1.6× 2.2k 1.8× 732 1.5× 466 1.3× 500 1.4× 93 3.8k
Sylvia Stöckler‐Ipsiroglu Canada 30 1.3k 1.0× 954 0.8× 522 1.1× 477 1.3× 333 0.9× 103 2.5k
N. G. G. M. Abeling Netherlands 25 566 0.5× 943 0.8× 297 0.6× 228 0.6× 231 0.7× 84 2.0k
Jean Marie Saudubray France 35 2.1k 1.7× 1.9k 1.6× 638 1.3× 337 0.9× 491 1.4× 88 3.5k
Belén Pérez‐Dueñas Spain 28 853 0.7× 847 0.7× 349 0.7× 359 1.0× 164 0.5× 109 2.0k
Deborah Marsden United States 24 1.2k 1.0× 854 0.7× 532 1.1× 283 0.8× 391 1.1× 65 1.8k
Hiroshi Mitsubuchi Japan 23 687 0.5× 775 0.6× 390 0.8× 188 0.5× 278 0.8× 92 2.0k
Nobuo Sakura Japan 25 889 0.7× 843 0.7× 470 1.0× 433 1.2× 484 1.4× 102 2.1k

Countries citing papers authored by Jaume Campistol

Since Specialization
Citations

This map shows the geographic impact of Jaume Campistol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaume Campistol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaume Campistol more than expected).

Fields of papers citing papers by Jaume Campistol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaume Campistol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaume Campistol. The network helps show where Jaume Campistol may publish in the future.

Co-authorship network of co-authors of Jaume Campistol

This figure shows the co-authorship network connecting the top 25 collaborators of Jaume Campistol. A scholar is included among the top collaborators of Jaume Campistol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaume Campistol. Jaume Campistol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tenorio, Jair, Pedro Arias, Feliciano J. Ramos, et al.. (2019). MRX93 syndrome ( BRWD3 gene): five new patients with novel mutations. Clinical Genetics. 95(6). 726–731. 7 indexed citations
2.
Montero, Raquel, Dèlia Yubero, Marı́a Julieta González, et al.. (2019). Plasma coenzyme Q10 status is impaired in selected genetic conditions. Scientific Reports. 9(1). 793–793. 28 indexed citations
3.
Campistol, Jaume. (2016). Epilepsy in Inborn Errors of Metabolism With Therapeutic Options. Seminars in Pediatric Neurology. 23(4). 321–331. 14 indexed citations
4.
Arroyo, H, et al.. (2013). Actualizaciones en neurología infantil IV. Medicina-buenos Aires. 73. 0–0.
5.
Campistol, Jaume. (2013). Orientación diagnóstica de las enfermedades neurometabólicas basada en la clínica, estudios metabólicos y neuroimagenológicos. SHILAP Revista de lepidopterología. 73. 55–62. 2 indexed citations
6.
Armstrong, Judith, et al.. (2012). CDKL5 in different atypical Rett syndrome variants: Description of the first eight patients from Spain. 1(1). 27–35. 7 indexed citations
7.
Pérez‐Dueñas, Belén, Jaume Campistol, Verónica González, et al.. (2011). Novel features in the evolution of adenylosuccinate lyase deficiency. European Journal of Paediatric Neurology. 16(4). 343–348. 13 indexed citations
8.
Alcaide, Patricia, B. Merinero, Pedro Ruiz‐Sala, et al.. (2010). Defining the pathogenicity of creatine deficiency syndrome. Human Mutation. 32(3). 282–291. 27 indexed citations
9.
Fons, Carmen, Ángela Arias, Pilar Rodríguez‐Pombo, et al.. (2009). Deficiencia cerebral de creatina: primeros pacientes españoles con mutaciones en el gen GAMT. Medicina Clínica. 133(19). 745–749. 7 indexed citations
10.
Serrano, Mercedes, Belén Pérez‐Dueñas, Carmen Fons, et al.. (2009). Neuropsychiatric Manifestations in Late-Onset Urea Cycle Disorder Patients. Journal of Child Neurology. 25(3). 352–358. 27 indexed citations
11.
Gassió, Rosa, et al.. (2008). Cognitive functions and the antioxidant system in phenylketonuric patients.. Neuropsychology. 22(4). 426–431. 31 indexed citations
12.
Serrano, Mercedes, Belén Pérez‐Dueñas, Aída Ormazábal, et al.. (2008). Levodopa therapy in a Lesch‐Nyhan disease patient: Pathological, biochemical, neuroimaging, and therapeutic remarks. Movement Disorders. 23(9). 1297–1300. 13 indexed citations
13.
Donati, Filippo, Giuseppe Gobbi, Jaume Campistol, et al.. (2007). The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure. 16(8). 670–679. 54 indexed citations
14.
15.
Ormazábal, Aída, Àngels García‐Cazorla, Belén Pérez‐Dueñas, et al.. (2006). Determination of 5-methyltetrahydrofolate in cerebrospinal fluid of paediatric patients: Reference values for a paediatric population. Clinica Chimica Acta. 371(1-2). 159–162. 39 indexed citations
16.
Campistol, Jaume, et al.. (2005). Analysis of the characteristics of epilepsy in 37 patients with the molecular diagnosis of Angelman syndrome. Epileptic Disorders. 7(1). 19–25. 39 indexed citations
17.
Pérez‐Dueñas, Belén, María Antònia Vilaseca, Anna Mas, et al.. (2004). Tetrahydrobiopterin responsiveness in patients with phenylketonuria. Clinical Biochemistry. 37(12). 1083–1090. 41 indexed citations
18.
Artuch, Rafael, Catrina Colomé, Cristina Sierra, et al.. (2003). A longitudinal study of antioxidant status in phenylketonuric patients. Clinical Biochemistry. 37(3). 198–203. 57 indexed citations
19.
Milà, Montserrat, et al.. (1999). Biochemical Phenotype and Its Relationship with Genotype in Hyperphenylalaninemia Heterozygotes. Molecular Genetics and Metabolism. 67(2). 156–161. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026